Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million ...

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

Trump's deadlines for tariffs, federal worker buyouts and RTO, federal funding freeze, TikTok, and more are coming up. Here's ...

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

GI Innovation announced on the 20th that it has signed a memorandum of understanding (MOU) with the Chinese bio company ...

Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, while Intel’s ...

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications ...

The ASX 200 benchmark touched an all-time record of 8566 points before pulling back slightly. At around lunch time Friday, ...

Mr. John DeLucia, as a well-respected Regulatory Consultant, is representing Izotropic in its pre-submission interactions with FDA while ensuring the Company's proposals, documentation, filings, and ...

European markets closed higher on Friday, buoyed by robust Chinese growth data and merger talks in the mining sector. Germanys DAX rose 1.3%, Frances CAC 40 gained over 1%, and the UKs FTSE 100 surged ...

But if Kennedy hopes to target junk food ... Part of Kennedy's new mandate will include overseeing the US Food and Drug Administration (FDA), which has over 18,000 employees.